Upadacitinib
3 NDCs across 1 manufacturer|0 Generic,3 Brand
Upadacitinib is used to treat rheumatoid arthritis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Aug 16, 2019. In 2024, Medicare Part D spent $1.4 billion on Upadacitinib across 194,000 claims for 29,000 beneficiaries.
Upadacitinib is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $229.24 to $459.41 per EA — the most expensive product costs about 2.0× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
0G / 3B
Manufacturers
1
competing in market
Price Spread
$229.24 – $459.41
per EA
7d Activity
avg +0.2% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing UPADACITINIB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
RINVOQ ER 45 MG TABLET | $459.4143 per EA | +0.04% |
RINVOQ ER 15 MG TABLET | $229.2749 per EA | +0.15% |
RINVOQ ER 30 MG TABLET | $229.2366 per EA | +0.28% |
Frequently Asked Questions
What is Upadacitinib used to treat?
Upadacitinib is used to treat rheumatoid arthritis, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Upadacitinib?
In 2024, Medicare Part D spent $1.4 billion on Upadacitinib across 194,000 claims for 29,000 beneficiaries.
How many Upadacitinib products are on the market?
The Upadacitinib drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.
What is the price range for Upadacitinib?
NADAC reference prices for Upadacitinib range from $229.2366 to $459.4143 per EA — the most expensive product costs about 2.0× the cheapest.
Which manufacturers make Upadacitinib?
1 manufacturer lists Upadacitinib in NADAC. Ranked by number of NDCs, the largest are AbbVie Inc. (3).
How has the price of Upadacitinib changed recently?
Over the past 7 days, 3 Upadacitinib NDCs rose and 0 fell, with a market-wide average change of +0.2%.